# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.
Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Entrada Therapeutics (NASDAQ:TRDA) with a Buy and maintains $2...
Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate o...